Abstract: In some embodiments, a method of simulating combat described herein comprises emitting a first query beam from a first query unit of a first interoperable identification and communication system, receiving the first query beam with a second response unit of a second interoperable identification and communication system, emitting a second response beam with the second response unit, and receiving the second response beam with the first query unit. In some embodiments, a method of simulating combat comprises emitting a query beam comprising a plurality of packets each comprising a header portion, an information portion, and a footer portion from a query unit; and receiving the query beam with a response unit comprising a plurality of detectors spatially separated from one another, wherein the response unit is operable to independently measure the intensity of each packet of the query beam received at each of the plurality of detectors.

Abstract: In one aspect, identification and communication systems are described herein. In some embodiments, an identification and communication system comprises one or more query units and one or more response units, wherein at least one query unit comprises a query beam source comprising a light emitting diode (LED) operable to emit a query beam. In some embodiments, the query beam is substantially collimated. In some embodiments, an identification and communication system comprises one or more query units and one or more response units, wherein at least one query unit comprises a first query beam source operable to emit a first component beam and a second query beam source operable to emit a second component beam. In some embodiments, the first query beam source comprises an LED and the second query beam source comprises a laser. In some embodiments, the first component beam and the second component beam are substantially concentric.

Abstract: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.

Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.

Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.

Abstract: Software (such as server products) operating in a complex networked environment often run on multi-machine installations that are known as machine clusters. A server product can be tested on a server machine type. The server product can be tested by tracking the constituent machines of a machine cluster, and configuring and recording the roles that each machine in the machine cluster plays. Scenarios targeting a single server machine-type can be seamlessly mapped from the single machine scenario to a machine cluster of any number of machines, while handling actions such as executing tests and gathering log files from all machines of a machine cluster as a unit.

Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.

Abstract: Methods for the treatment of cancer with combination therapies that include anti-VEGF antibodies are provided. Methods for diagnosing resistant tumors are also provided.

Abstract: Methods for the treatment of Hodgkin's lymphoma comprising administering both a chemotherapeutic regimen and an antibody-drug conjugate compound to a subject in need thereof are provided.

Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.

Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.

Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.

Abstract: An integrated test framework is disclosed that allows software testers to easily generate and execute tests of software involving multiple interacting computer systems. A copy of the integrated test framework resides on each computer system in the test. The integrated test framework on each computer system supports the independent testing of software on that system and also the synchronization between the computer systems. A test manager is provided to coordinate the synchronization. All the information necessary to direct the test framework on each of the computer systems is included within a single test script that is propagated to and executed on each computer system. The test script dictates the role of each computer system within the test and includes role specific actions and identifies points at which the computer systems must synchronize together for the passing of data, messages or other communications.

Abstract: A test services provider is an object that is arranged to provide a standardized interface for calling test harness provided functionality. The test services provider is not tied to a specific test harness, and provides a standard interface such that both test harness functionality and test cases can be written without beforehand knowledge of the other. In operation, the test harness registers the test services that provides with the test service provider, and the test cases retrieve the registered test services from the test harness as needed. Accordingly, the test case does not have to query the test harness itself for the object that provides the desired test harness functionality, but rather uses a standardized interface provided by the test services provider to retrieve the desired test services.

Abstract: Software automation testing and validation are provided according to a system that runs automation tests using multiple lab machines and allows the testing to be performed before checking in the code to a version control system. Code changes in a build of the software are provided on a computing device. Automation tests are selected from a list of available tests. When indicated by a job queue, the changed code of the build is forwarded to lab machines allocated by an automation system. An image of the build from the computing device is generated on the lab machines and the automation tests are run against the build. A report is generated and forwarded back to one or more recipients that notifies of the success or failure of the automation testing.

Abstract: The present invention is directed towards a test case inheritance behavior that can be controlled via attributes. A base test class from which test objects are derived are useful for reducing test case code and management. For example, base test classes and their derived objects can be used to implement steps that are common between the entire set of classes (e.g., launching a piece of software to be tested and getting it to a certain stage). The principle of inheritance simplifies management of the test software when, for example, the base class is modified, all of the tests which derive from that test case automatically are modified. Accordingly, only one item needs to be modified (instead of every tests) when a change is necessary to modify the way the software launches.

Abstract: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.

Abstract: The present invention is directed to methods and means for making and using Angptl3 polypeptides. The invention specifically concerns the use of Angptl3 polypeptides in inducing liver regeneration and angiogenesis. Further methods include the use of Angptl3 polypeptides in the diagnosis and treatment of liver disease. Also provided herein are antibodies which bind to the polypeptides of the present invention.

Abstract: The invention provides methods and compositions useful for modulating vascular integrity.

Abstract: Software (such as server products) operating in a complex networked environment often run on multi-machine installations that are known as machine clusters. A server product can be tested on a server machine type. The server product can be tested by tracking the constituent machines of a machine cluster, and configuring and recording the roles that each machine in the machine cluster plays. Scenarios targeting a single server machine-type can be seamlessly mapped from the single machine scenario to a machine cluster of any number of machines, while handling actions such as executing tests and gathering log files from all machines of a machine cluster as a unit.